In vitro fungicidal activities of voriconazole, itraconazole, and amphotericin B against opportunistic moniliaceous and dematiaceous fungi
about
Voriconazole versus amphotericin B or fluconazole in cancer patients with neutropeniaVoriconazole versus amphotericin B in cancer patients with neutropeniaVoriconazole versus amphotericin B and fluconazole in cancer patients with neutropeniaAntifungal activities of posaconazole, ravuconazole, and voriconazole compared to those of itraconazole and amphotericin B against 239 clinical isolates of Aspergillus spp. and other filamentous fungi: report from SENTRY Antimicrobial Surveillance PMelanized fungi in human diseaseActivities of caspofungin, itraconazole, posaconazole, ravuconazole, voriconazole, and amphotericin B against 448 recent clinical isolates of filamentous fungi.Susceptibility of filamentous fungi to voriconazole tested by two microdilution methodsPharmacokinetics of liposomal amphotericin B in pleural fluid.Scedosporium apiospermum soft tissue infection successfully treated with voriconazole: potential pitfalls in the transition from intravenous to oral therapy.Functional analysis of CaIPT1, a sphingolipid biosynthetic gene involved in multidrug resistance and morphogenesis of Candida albicans.Voriconazole: the newest triazole antifungal agentConidial viability assay for rapid susceptibility testing of Aspergillus species.Progressive cutaneous hyalohyphomycosis due to Paecilomyces lilacinus: rapid response to treatment with caspofungin and itraconazole.Testing conditions for determination of minimum fungicidal concentrations of new and established antifungal agents for Aspergillus spp.: NCCLS collaborative study.Optimal testing conditions for determining MICs and minimum fungicidal concentrations of new and established antifungal agents for uncommon molds: NCCLS collaborative study.Epidemiology, clinical manifestations, and therapy of infections caused by dematiaceous fungi.Antifungals targeted to protein modification: focus on protein N-myristoyltransferase.Voriconazole: a new triazole antifungal agent.Scedosporium prolificans osteomyelitis in an immunocompetent child treated with voriconazole and caspofungin, as well as locally applied polyhexamethylene biguanideSpecific antifungal susceptibility profiles of opportunists in the Fusarium fujikuroi complex.Scedosporium species infections and treatments.Determination of fungicidal activities against yeasts and molds: lessons learned from bactericidal testing and the need for standardization.Guidelines for the use of antifungal agents in the treatment of invasive Candida and mould infections.Choices aplenty: antifungal prophylaxis in hematopoietic stem cell transplant recipients.In vitro analyses, animal models, and 60 clinical cases of invasive Aspergillus terreus infection.Improved outcome of zygomycosis in patients with hematological diseases?Penicillium marneffei infection presenting as vulv-ulcer in an HIV-infected woman.The iron chelator deferasirox protects mice from mucormycosis through iron starvationCombination treatment of invasive fungal infections.Diagnosis of fusariosis in urine cytologyDifferential fungicidal activities of amphotericin B and voriconazole against Aspergillus species determined by microbroth methodology.Therapy of infections caused by dematiaceous fungi.Human phagocytic cell responses to Scedosporium apiospermum (Pseudallescheria boydii): variable susceptibility to oxidative injuryTreatment of invasive fungal infections in clinical practice: a multi-centre survey on customary dosing, treatment indications, efficacy and safety of voriconazole.Dematiaceous fungi.Paecilomyces lilacinus infection in a liver transplant patient: case report and review of the literature.New and investigational triazole agents for the treatment of invasive fungal infections.Blad-Containing Oligomer Fungicidal Activity on Human Pathogenic Yeasts. From the Outside to the Inside of the Target Cell.New triazoles and echinocandins: mode of action, in vitro activity and mechanisms of resistance.Pharmacology and clinical use of voriconazole.
P2860
Q24200304-55194C54-FFC4-45C7-BC82-8F1CB626416BQ24244950-432055AA-E762-442D-B91C-E91FE23ACCA7Q24247337-3A89C694-FA9B-48F0-99BF-6BE88256A5FDQ24535844-44E6A8C3-033D-4D5B-9344-A2947A7CA98BQ24633163-1E68ABD9-9EF3-4D71-BC93-6F0DC4F6BA41Q33188045-308885ED-9489-44C6-A71F-CB39452AB190Q33592487-FE22A90F-8556-4E46-B971-4C2C70D508DBQ33768861-FBFBC15E-85EA-42F2-91A9-02AFD5F0081BQ33824506-F5187A00-5114-47E9-9B21-ACB9498644B8Q33937992-BCAE0C99-FDFE-4135-92FC-0DE26C7408AFQ33946021-7AD36503-CDF7-4856-9595-6D5857B776D9Q33963764-08A7D346-6B2E-450C-A152-25E09CFBE969Q34125983-4808B43F-0858-45B8-B58F-C08596D93F45Q34195380-725173AC-E1C0-41C9-B45A-A07500D132B0Q34202213-024496DF-EBF1-4B57-B487-B1C1821513DAQ34288185-41506461-EF8A-43AC-98F7-88BB8F8A9E72Q34768569-202E00F5-59D2-4B4D-9734-52341F2A2C37Q35069136-6FE4F88A-2CE7-4F70-A4A1-971DAF49D822Q35194598-0E1652A2-559C-4F0A-A315-AB8497F0F984Q35533576-994A49C1-16A1-4D45-B54B-2C4D576A7839Q35622016-989F8ACA-CB01-4065-AA24-7747567FABF5Q35745822-D864BF44-BD6B-48BF-B1E7-A384D1A8BFABQ35746695-2699040D-585C-4FC3-B06A-DFCEAC5A4459Q35833407-AE0F50CA-7D55-4BA7-B3ED-55BB9D391680Q35870651-6FA647E1-2268-4E35-9B88-0CA3AFA9D8A2Q35883785-1140CE57-4726-4515-82E4-2487D5D08051Q35959714-634F0E86-185E-4D9C-856B-4E06047E831DQ35960985-1FFFC7C4-BE4D-4C5F-806D-F473225DF4F8Q36011378-BF2EE34F-207D-4814-AA8A-C72C1B338FA3Q36026130-68C087E9-E036-46DE-A342-A39506D64FEEQ36094939-DA37B7DA-6887-4215-906A-FEE56FE86310Q36233517-92F3F73E-4568-4D07-8107-A3212230831DQ36376608-892DD47E-41BA-4699-9F00-A6548CCBC1F8Q36511881-D8F394D0-BB79-4C52-8FF0-E05630F057FAQ36738130-E5FD308A-7A1F-4943-81C5-96BD3B8B2EFEQ36867452-B60D037B-FA56-4EA8-AA7E-4A3D303B9256Q37364295-D32DB9E6-E014-4F06-AA19-75B9A8782BEFQ37438608-C11EB8FD-4F11-4CA4-8597-5DCFFD3724E6Q37608276-4B9E15D3-3521-4C43-94E8-210DC517611AQ37641375-C72AE5F0-6F71-4657-9062-40D914135875
P2860
In vitro fungicidal activities of voriconazole, itraconazole, and amphotericin B against opportunistic moniliaceous and dematiaceous fungi
description
2001 nî lūn-bûn
@nan
2001 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մարտին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
In vitro fungicidal activities ...... iaceous and dematiaceous fungi
@ast
In vitro fungicidal activities ...... iaceous and dematiaceous fungi
@en
In vitro fungicidal activities ...... iaceous and dematiaceous fungi
@nl
type
label
In vitro fungicidal activities ...... iaceous and dematiaceous fungi
@ast
In vitro fungicidal activities ...... iaceous and dematiaceous fungi
@en
In vitro fungicidal activities ...... iaceous and dematiaceous fungi
@nl
prefLabel
In vitro fungicidal activities ...... iaceous and dematiaceous fungi
@ast
In vitro fungicidal activities ...... iaceous and dematiaceous fungi
@en
In vitro fungicidal activities ...... iaceous and dematiaceous fungi
@nl
P2860
P1476
In vitro fungicidal activities ...... iaceous and dematiaceous fungi
@en
P2093
A Espinel-Ingroff
P2860
P356
10.1128/JCM.39.3.954-958.2001
P407
P577
2001-03-01T00:00:00Z